Showing results (251-260 of 305) with videos related to
Sort By:
Pageof 31
The Lancet. Oncology|December 17, 2022
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trialRoberto Mina, Pellegrino Musto, Delia Rota-Scalabrini, et al.Blood|February 26, 2005
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcomeMarco Ladetto, Sonia Vallet, Andreas Trojan, et al.Blood|August 16, 2011
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)Antonio Palumbo, Sara Bringhen, Heinz Ludwig, et al.Blood|August 13, 2011
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomideAlessandra Larocca, Federica Cavallo, Sara Bringhen, et al.Blood Cancer Journal|June 7, 2024
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cellsMattia D'Agostino, Delia Rota-Scalabrini, Angelo Belotti, et al.American Journal of Hematology|June 18, 2026
The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN)Heinz Ludwig, Evangelos Terpos, Francesca Gay, et al.Blood|March 31, 2011
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantationMichele Cavo, S Vincent Rajkumar, Antonio Palumbo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple MyelomaLuca Bertamini, Stefania Oliva, Delia Rota-Scalabrini, et al.Hemasphere|November 15, 2019
Insights on Multiple Myeloma Treatment StrategiesMaría-Victoria Mateos, Heinz Ludwig, Ali Bazarbachi, et al.Journal of Hematology & Oncology|January 11, 2019
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trialIlaria Saltarella, Fortunato Morabito, Nicola Giuliani, et al.Pageof 31